Heart transplant patients who live in socioeconomically disadvantaged areas are more likely to experience post-surgical complications and die within five years than patients who live in more advantaged areas, even when those patients were transplanted at topnotch high-volume hospitals.
A heart transplant is a lifesaving gift. But it means adjusting to a new way of life. Without anti-rejection measures, the body’s immune system will reject the transplanted heart.
BACKGROUNDCerebrovascular accident (CVA) is a major global contributor to death and disability. As part of its medical management, researchers have recognized the importance of promising neuroprotective strategies, where stem cell transplan
BACKGROUNDCerebrovascular accident (CVA) is a major global contributor to death and disability. As part of its medical management, researchers have recognized the importance of promising neuroprotective strategies, where stem cell transplan
Children’s Hospital Los Angeles cardiologist Jondavid Menteer, MD, was honored with the World Children’s Transplant Fund “WCTF for the Children Award.” The prestigious award recognized Dr. Menteer for 20 years of dedication and leadership in pediatric heart transplant at Children’s Hospital Los Angeles, which is home to the largest heart center for children in the Western U.S.
Open Disparities Narrowing Among Patients Undergoing Blood Stem Cell Transplant, Roswell Park Study Reveals configuration options Historically, some patients with blood cancers have been less likely than others to receive stem cell transplant, also known as bone marrow transplant.
It was truly a Labor Day weekend to remember at Vanderbilt University Medical Center, where transplant teams performed 10 kidney transplants in two days — and that was before even getting to Labor Day.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Receiving a liver transplant means also living with the possibility of rejection. Transplant rejection occurs when the body’s immune system attacks the new organ. This risk is highest in the first year after the transplant, but rejection can happen at any time. To prevent this, patients take powerful medications to suppress their immune system and reduce inflammation.
On Sunday, September 8, a 27-year-old Loyola Medicine patient will meet for the first time the Arizona man who donated bone marrow on three separate occasions to help save her life.
Investigators involved in a multicenter study co-led by Cedars-Sinai discovered a pathway by which immune cells prevent the lungs’ protective barrier from healing after viral infections like COVID-19. The findings, published in Nature, may lead to new therapeutic treatment options.
20240326113011.png&width=400&height=400){kind=logo}
Looking to extend the viability of human tissues, researchers report in ACS’ Nano Letters their efforts to facilitate completely freezing, rather than cooling and then thawing, potentially life-saving organs for transplant. They demonstrate a magnetic nanoparticle’s successful rewarming of animal tissues.
Sadly, only 20 percent of lung transplant recipients survive beyond the 10-year mark, a fact that is not lost on Diane Williams as she celebrates the tenth anniversary of her transplant. After suffering from idiopathic pulmonary fibrosis, a debilitating lung disease that causes scarring of the lungs, Williams received a life-saving lung transplant in 2014.
Researchers from Michigan State University and Corewell Health, in collaboration with Cleveland Clinic, have made a significant breakthrough in understanding post-COVID-19 lung complications.
Researchers determined that transplant patients who receive kidneys infected with the parasite toxoplasma have virtually the same outcomes as those who receive toxoplasma-negative organs.
Liver transplant is considered the best treatment for liver cancer, but only available for patients with early-stage disease. Now a study led by Cedars-Sinai Cancer investigators has concluded that immunotherapy could make liver transplant an option for patients with later-stage cancer as well.
A discovery by a three-member Albert Einstein College of Medicine research team may boost the effectiveness of stem-cell transplants, commonly used for patients with cancer, blood disorders, or autoimmune diseases caused by defective stem cells, which produce all the body’s different blood cells.
The UCSF Lung Transplant Program has performed over 100 transplants in a year, making it one of a handful of medical centers in the nation to reach that milestone.
Dr. Vikas Dharnidharka will join Rutgers Robert Wood Johnson Medical School as Henry Rutgers Professor and chair of the Department of Pediatrics and also will serve as physician-in-chief of The Bristol-Myers Squibb Children’s Hospital (BMSCH) at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility.
Thermo Fisher Scientific Inc. will showcase its broad diagnostics portfolio and host a series of customer-led workshops and presentations that highlight industry developments and the company’s latest innovations during the Association for Diagnostics & Laboratory Medicine Conference (ADLM) July 28-Aug. 1, 2024, in Chicago, Ill.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right